September 2026

Join WhatsApp Channel 

GPAT caoching
Require Plant HR – Talent Acquisition at Aculife
18 September 2026

Require Plant HR – Talent Acquisition at Aculife

ACULIFE HEALTHCARE PRIVATE LIMITED, Aculife has been associated with the healthcare segment since over last 30 years now, which is the prime reason why the name spells unparalleled growth and absolute reliability.
Work as Clinical Research Associate at ICON plc
18 September 2026
Work as Clinical Research Associate at ICON plc
You will be embedded in our client's study team and have a dedicated ICON line manager to support you. Oversees all aspects of study site management to ensure high quality data resulting in consistently low query levels and in good Quality Assurance reports
Takeda and Dr. Reddy’s Partner to Promote and Distribute QDENGA® in India’s Private Pediatric and Adult Market
18 September 2026
Takeda and Dr. Reddy’s Partner to Promote and Distribute QDENGA® in India’s Private Pediatric and Adult Market
QDENGA®, across India’s private market for pediatric and adult vaccination in India. Subject to completion of applicable processes with local authorities, the vaccine is anticipated to become available in the first half of 2027.
FDA Expands Finerenone Approval to Type 1 Diabetes-Linked Kidney Disease
18 September 2026
FDA Expands Finerenone Approval to Type 1 Diabetes-Linked Kidney Disease
The U.S. Food and Drug Administration (FDA) has approved Kerendia (finerenone) for a new indication in adults with chronic kidney disease (CKD) associated with type 1 diabetes (T1D). Bayer announced it as the first FDA-approved treatment option in more than 30 years for adults with CKD associated with type 1 diabetes
FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
18 September 2026
FDA Approves First Gene Therapy for Pediatric Patients with Sanfilippo Syndrome Type A
Sanfilippo syndrome type A is a rare inherited disorder that primarily affects the brain and nervous system. Children with the condition can experience progressive loss of cognitive, language and other developmental abilities. Before this approval, there was no FDA-approved treatment specifically designed to address the underlying cause of MPS IIIA
Operation TrialBlazer: The US Plan to Bring Clinical Trials Back Home
18 September 2026
Operation TrialBlazer: The US Plan to Bring Clinical Trials Back Home

Operation TrialBlazer is a coordinated, department-wide initiative launched by the US Department of Health and Human Services (HHS) on June 22, 2026, aimed at restoring America's leadership in clinical research.

Vaccination: Why Don’t We All Experience the Same Side Effects?
18 September 2026
Vaccination: Why Don’t We All Experience the Same Side Effects?

Redness, pain at the injection site, fever, fatigue and headache are some of the common temporary reactions that can occur after vaccination. However, not everyone experiences these effects in the same way. While some people may develop noticeable symptoms after vaccination, others may experience little or no reaction at all.

New research from the Center for Vaccinology at the University of Geneva (UNIGE) and Geneva University Hospitals (HUG) has identified a possible biological explanation for these differences.

CIMAP inviting applications from Pharmacy, Life sciences, Biotech, Microbiology candidates | Hiring Project Assistant, Project Associate, Project Scientist - 64 vacancies
17 September 2026
CIMAP inviting applications from Pharmacy, Life sciences, Biotech, Microbiology candidates | Hiring Project Assistant, Project Associate, Project Scientist - 64 vacancies

CSIR-Central Institute of Medicinal and Aromatic Plants (CSIR-CIMAP) is a premier research institute under the Council of Scientific & Industrial Research (CSIR), focusing on medicinal and aromatic plants. Established in 1959, the institute conducts research in areas such as plant biotechnology, phytochemistry, agronomy, pharmacology, and natural product development. CSIR-CIMAP works on the development of improved varieties, cultivation technologies, herbal products, and value-added products from medicinal and aromatic plants.

Meghalayan Medical Drugs & Services inviting Pharmacists | Master of Pharmacy can apply for nine positions
17 September 2026
Meghalayan Medical Drugs & Services inviting Pharmacists | Master of Pharmacy can apply for nine positions

Application from citizens of Meghalaya are urgently required for appointment on a contractual basis for a period of 2 years (renewable) for the following post under Meghalayan Medical Drugs & Services Ltd, Meghalaya

Post: Pharmacist

NIPER announces hiring of Scientists in Preclinical studies - MPharm / MSc or Phd in pharmaceutical sciences
17 September 2026
NIPER announces hiring of Scientists in Preclinical studies - MPharm / MSc or Phd in pharmaceutical sciences

National Institute of Pharmaceutical Education and Research (NIPERs) have been created by an act of Parliament and each institute is an autonomous body functioning under the Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers, Govt. of India. Having been declared as “Institutes of National Importance”. NIPERs have been contributing to the growth of the Pharmaceutical Education and Research to meet the country's progress towards skilled professionals in the pharmaceutical industry.